Pulmonary Valve Regurgitation

Overview

Pulmonary valve regurgitation is a condition in which the pulmonary valve (located between the heart's right lower chamber and the pulmonary artery, the large vessel carrying blood to the lungs) does not close fully after each heartbeat. When the right lower chamber contracts, a healthy pulmonary valve opens to send blood to the lungs and then closes tightly to prevent any backward flow. In pulmonary regurgitation, the valve fails to seal properly and some of the oxygenated blood returning from the lungs leaks back into the right lower chamber.

Because the right lower chamber must now pump this extra volume of blood with each beat, it gradually becomes overloaded and enlarges. The heart can often compensate for years without symptoms. Over time, however, the walls of the right lower chamber thin and weaken, and right heart failure can develop.

Pulmonary valve regurgitation most often develops as a consequence of surgical repair of congenital heart disease, particularly tetralogy of Fallot. In these operations, the pulmonary valve frequently needs to be widened or removed to relieve obstruction, and regurgitation is an almost inevitable long-term result. Lifelong cardiology follow-up after such surgery is therefore essential.

Symptoms

Mild to moderate pulmonary valve regurgitation may produce no symptoms for many years. As the right lower chamber progressively enlarges under the sustained volume load, symptoms develop gradually and are often attributed to general deconditioning before the true cause is recognized.

• Reduced exercise capacity. This is often the earliest and most commonly noticed change. Physical activities that were previously manageable become progressively more tiring or cause breathlessness more quickly. Because this decline happens slowly, it can easily be mistaken for the effects of aging or inactivity.
• Shortness of breath. This may occur particularly during physical exertion. As the right lower chamber enlarges and its efficiency declines, breathing can become more difficult with effort.
• Fatigue and weakness. When the body receives less blood than it needs, a persistent sense of exhaustion may develop and daily activities can feel increasingly demanding.
• Palpitations or irregular heartbeat. An enlarging right lower chamber creates conditions for rhythm disturbances. Ventricular arrhythmias and atrial fibrillation are both important concerns in this patient group. The heart may feel as though it is racing, fluttering, or beating irregularly.
• Swelling in the legs and ankles. When right heart failure develops, fluid accumulates in the body.
• Dizziness. Reduced cardiac output from the right lower chamber can occasionally produce feelings of lightheadedness or unsteadiness.

When to Seek Medical Care

People who have had surgery for congenital heart disease and those with known pulmonary regurgitation should contact their doctor if they notice any of the following.

• A noticeable and progressive decline in exercise capacity
• Shortness of breath during activity or at rest
• Swelling in the legs or ankles
• Palpitations or a sensation of irregular heartbeat
• A missed follow-up appointment, since regular monitoring is critically important in this group

Call emergency services immediately if you experience any of the following.

• Sudden, severe shortness of breath
• Fainting or nearly fainting
• A very rapid or markedly irregular heartbeat
• Sudden, severe chest pain

Causes

The majority of pulmonary valve regurgitation cases arise as a consequence of surgical treatment for congenital heart disease. This means the condition most often presents in adulthood as a delayed result of cardiac surgery performed in childhood.

• Tetralogy of Fallot repair. The most common cause. Tetralogy of Fallot is a combination of four congenital structural heart abnormalities. Surgical correction of this condition frequently requires widening or removing the pulmonary valve to relieve the obstruction. Pulmonary regurgitation follows this surgery in almost all cases. It may be well tolerated for years but gradually leads to right lower chamber enlargement and, if untreated, to right heart failure. Lifelong cardiology follow-up after tetralogy of Fallot repair is therefore non-negotiable.
• Other congenital heart surgery. Operations for pulmonary valve stenosis (whether by balloon valvuloplasty or surgery) can result in regurgitation if the valve is overly widened. Repair of pulmonary valve atresia can similarly lead to this condition.
• Pulmonary hypertension. Sustained elevated pressure in the lung vessels can stretch the pulmonary valve ring and prevent the leaflets from closing fully.
• Infective endocarditis. Pulmonary valve infections are rare but can destroy leaflet tissue and cause regurgitation.
• Rheumatic fever. Extremely rare as a cause of pulmonary regurgitation. When it does occur, other valves are almost always involved as well.
• Carcinoid syndrome. Hormones produced by certain digestive system tumors can damage the pulmonary valve leaflets.
• Idiopathic. Trivial to mild pulmonary regurgitation with no identifiable cause is not uncommon and is most often discovered incidentally. It carries very little clinical significance in most people.

Risk Factors

• Prior surgery for tetralogy of Fallot or another congenital heart condition. The most important risk factor by far. All patients in this group require lifelong monitoring.
• Prior balloon valvuloplasty for pulmonary stenosis. Pulmonary regurgitation can develop after this procedure and requires monitoring over time, though it is often mild.
• Pulmonary hypertension. Elevated lung vessel pressure places ongoing strain on the pulmonary valve ring and can contribute to regurgitation.

Diagnosis

The diagnosis of pulmonary valve regurgitation is established through clinical assessment and imaging. Accurately measuring the volume of regurgitation and the state of the right lower chamber is essential for determining the timing of intervention. Cardiac MRI plays a uniquely important role in this condition.

• Medical history and physical examination. The onset and progression of symptoms are discussed. A detailed history of any prior congenital heart surgery is obtained. On examination, a soft murmur heard during diastole, the relaxation phase when the pulmonary valve should be closed, may indicate pulmonary regurgitation. However, the murmur of pulmonary regurgitation can be subtle and easy to miss, which is why imaging is always required.
• Echocardiogram (heart ultrasound). The first-line imaging tool for diagnosis and ongoing monitoring. It shows the closing behavior of the pulmonary valve and identifies backward flow in real time. It assesses the size, wall thickness, and contractile function of the right lower chamber. However, echocardiography is less accurate than cardiac MRI for measuring right lower chamber volumes and the true amount of regurgitation.
• Cardiac MRI. The gold standard for evaluating pulmonary valve regurgitation. It provides highly precise measurements of right lower chamber volume and function, and it quantifies the regurgitation fraction (the percentage of blood leaking backward) with accuracy that echocardiography cannot match. The decision about when to intervene is based primarily on right lower chamber volume thresholds, and cardiac MRI is the most reliable way to track these. For anyone who has had surgery for congenital heart disease, cardiac MRI is an indispensable part of regular follow-up.
• Electrocardiogram (ECG). Used to detect electrical changes related to right lower chamber enlargement and hypertrophy. Right bundle branch block is very commonly seen in this patient group as an electrical trace of prior surgery. Rhythm disturbances are also identified.
• Holter monitor. Worn for 24 hours or longer to detect ventricular arrhythmias or atrial fibrillation during normal daily activity. Ventricular tachycardia is a meaningful risk in this group and Holter monitoring is an important part of routine surveillance.
• Exercise stress test. Used to objectively measure exercise capacity. A decline in exercise capacity can precede the development of symptoms and may influence the timing of intervention.

Treatment

Treatment of pulmonary valve regurgitation depends on the amount of regurgitation, the size and function of the right lower chamber, and whether symptoms are present. The central goal is to intervene before permanent right ventricular damage occurs. Timing is critical. Acting too early carries unnecessary surgical risk; acting too late risks irreversible right ventricular dysfunction that persists even after valve replacement.

Monitoring

Mild to moderate pulmonary regurgitation with a well-functioning right lower chamber can be followed for years with regular surveillance. Echocardiography and cardiac MRI are used at defined intervals to track right ventricular volumes, function, and the degree of regurgitation. When the right lower chamber approaches critical size thresholds or when symptoms develop, the decision to intervene is made.

Medications

Medications cannot correct the valve abnormality itself. They have a role in managing symptoms and complications when these arise.

• Diuretics. When right heart failure symptoms develop (leg swelling and breathlessness) diuretics remove excess fluid and provide meaningful symptomatic relief.
• Managing rhythm disturbances. Ventricular tachycardia and atrial fibrillation are important concerns in this group. Antiarrhythmic medications or catheter ablation may be used to manage these problems.
• Anticoagulation in atrial fibrillation. When atrial fibrillation develops, blood-thinning therapy may be required to reduce the risk of stroke.

Transcatheter Pulmonary Valve Implantation

In suitable patients who have previously undergone surgery for congenital heart disease and have since developed significant pulmonary regurgitation, a new pulmonary valve can be delivered through a catheter without open heart surgery.

A thin catheter is passed through a blood vessel in the groin or neck and guided through the right side of the heart to the pulmonary valve position. A new valve mounted on the catheter is positioned precisely in the correct location and then deployed, anchoring itself within the existing valve tissue or within a previously placed surgical conduit a tube-shaped channel placed during the original operation. Once the new valve is in place, the catheter is withdrawn.

The most significant advantage of this approach is that it eliminates the need for repeat open heart surgery. People with congenital heart disease may require multiple operations over their lifetime, and the risk associated with each successive surgery increases. Transcatheter valve replacement can meaningfully reduce this burden. Not all patients are anatomically suitable, however; the specific anatomy of the right lower chamber outflow and the pulmonary artery determines eligibility. Whether this approach is an option should be assessed at a center with expertise in adult congenital heart disease.

Surgical Pulmonary Valve Replacement

When transcatheter implantation is not feasible or when the anatomy is not suitable, open surgical valve replacement is performed. Biological valves are generally preferred for the pulmonary position because they carry less clotting risk than mechanical valves and have a relatively longer functional life in this location. Patients with a biological pulmonary valve do not require long-term anticoagulation.

The decision to operate is guided primarily by right ventricular volume thresholds measured on cardiac MRI. When established thresholds are exceeded, or when symptoms develop, surgery is recommended. Waiting too long (allowing the right lower chamber to enlarge well beyond critical limits) risks permanent dysfunction that may not resolve after valve replacement and can leave the patient with lasting limitations in exercise capacity.

Complications

Without adequate monitoring and timely intervention, pulmonary valve regurgitation can lead to serious and sometimes irreversible complications.

• Permanent right ventricular enlargement and dysfunction. The most important complication. Progressive volume overload causes the right lower chamber to enlarge and its walls to thin and weaken. Beyond a certain threshold, these changes may not fully reverse even after successful valve replacement. This is why the timing of intervention is so critical.
• Right heart failure. As the right lower chamber loses its pumping capacity, fluid accumulates in the body causing leg swelling, liver congestion, and severe fatigue.
• Ventricular arrhythmias and sudden cardiac arrest. The enlarged right lower chamber is prone to dangerous rhythm disturbances. Ventricular tachycardia can be life-threatening in this group and sudden cardiac arrest risk warrants close attention. An implantable cardioverter-defibrillator may be considered in selected high-risk patients.
• Atrial fibrillation. As the right upper chamber also enlarges, atrial fibrillation can develop, worsening symptoms and raising stroke risk.
• Permanently reduced exercise capacity. Damage to the right lower chamber that accumulates before valve replacement can leave lasting limitations on exercise capacity even after successful surgery. Timely intervention significantly reduces this risk.

Lifestyle

Most people living with pulmonary valve regurgitation had surgery for congenital heart disease in childhood. For this group, adult life brings its own set of medical priorities, and cardiology care must not be allowed to lapse.

Ongoing Cardiology Follow-up

The single most important lifestyle priority in this condition is consistent and uninterrupted cardiology monitoring. Follow-up frequency is determined by the degree of regurgitation and the state of the right lower chamber. Echocardiography and cardiac MRI are repeated at defined intervals. Holter monitoring and exercise testing are also part of routine surveillance. Missing appointments risks failing to detect right ventricular changes before they become irreversible.

Adult Congenital Heart Disease Centers

Follow-up for people who have had surgery for congenital heart disease should ideally take place at centers with specific expertise in adult congenital heart disease. These centers bring together cardiologists, cardiac surgeons, imaging specialists, and other experts who are familiar with the long-term consequences of congenital heart surgery and best placed to guide decisions about monitoring and intervention timing. The original surgical details (which are highly relevant to current management) are also better interpreted in this setting.

Physical Activity

People with mild to moderate pulmonary regurgitation and a well-functioning right lower chamber can generally maintain a near-normal level of physical activity. When significant right ventricular enlargement or dysfunction is present, high-intensity and competitive sport may not be appropriate. The specific type and intensity of exercise that is safe should be determined by your cardiologist based on your individual measurements and clinical situation rather than on symptoms alone.

Rhythm Disturbances

Ventricular rhythm disturbances and sudden cardiac arrest risk are more prominent in this group than in patients with most other valve conditions. Palpitations, dizziness, or fainting should always be reported to the doctor and evaluated promptly. An implantable cardioverter-defibrillator may be considered in selected high-risk patients to provide protection against sudden cardiac arrest.

Medications

Take all prescribed medications consistently and do not stop any without medical guidance. Always inform any other treating doctor about your congenital heart history and pulmonary valve regurgitation before a new medication is started.

Regular Follow-up

Pulmonary valve regurgitation requires lifelong monitoring. Contact your doctor or seek emergency care if any of the following develop.

• A noticeable and rapid decline in exercise capacity
• Shortness of breath that begins or worsens
• Swelling in the legs or ankles
• Palpitations, dizziness, or fainting
• Unexplained and significantly worsening fatigue

Preparing for Your Appointment

Coming prepared to an appointment for pulmonary valve regurgitation helps your doctor make a more accurate assessment and choose the most appropriate treatment for you.

What You Can Do

• Describe the type of congenital heart surgery you had and when it was performed. Bring surgical records if available.
• Write down when symptoms began and how they have progressed. Note any changes in your exercise capacity specifically.
• Bring previous echocardiography and cardiac MRI reports.
• List all medications and supplements you are currently taking.
• Write your questions down before the appointment.

Questions You May Wish to Ask Your Doctor

• How severe is my regurgitation and has my right lower chamber enlarged?
• Is surgery or a transcatheter procedure needed?
• Is transcatheter pulmonary valve implantation a suitable option for me?
• What type and intensity of exercise is safe for me?
• What is my risk of a dangerous rhythm disturbance and should I consider a defibrillator device?
• How often do I need follow-up appointments?

Questions Your Doctor May Ask You

• What congenital heart condition were you operated on for and when?
• When did symptoms begin and how have they progressed?
• Have you noticed any change in your exercise capacity?
• Have you experienced palpitations, dizziness, or fainting?
• What medications are you currently taking?
• When was your most recent echocardiogram or cardiac MRI?